Elon Musk's Neuralink said it has been cleared by the Food and Drug Administration to begin human trials on its brain-implant technology.
Why it matters: The company hopes to someday treat neurological disorders with a chip but has drawn scrutiny over animal testing and issues involving the lithium battery of the device, per Reuters.